Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache

被引:31
作者
Galeotti, N
Ghelardini, C
Zoppi, M
Del Bene, E
Raimondi, L
Beneforti, E
Bartolini, A
机构
[1] Univ Florence, Dept Pharmacol, I-50139 Florence, Italy
[2] Univ Florence, Dept Internal Med, Div Rheumatol, I-50139 Florence, Italy
[3] Univ Florence, Dept Internal Med, Headache Ctr, I-50139 Florence, Italy
关键词
D O I
10.1046/j.1468-2982.2001.00142.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The involvement of Gi proteins in the modulation of pain perception has been widely established, and mutations in G-proteins have already been identified as the aetiopathological cause of human diseases. The aim of the present study was to determine whether a deficiency or a hypofunctionality of the Gi proteins occurred in primary headache. The functionality and the level of expression of Gi proteins were investigated in lymphocytes from migraine without aura, migraine with aura and cluster headache sufferers. A reduced capability to inhibit forskolin-stimulated adenylyl cyclase activity in headache patients was observed. Migraine patients also showed basal adenosine cAMP levels about four times higher than controls. The reduced activity of Gi proteins seems not to be related to a reduction of protein levels since no significant reduction of the Gi(alpha) subunits was observed. These results indicate Gi protein hypofunctionality as an aetiopathogenic mechanism in migraine and cluster headache.
引用
收藏
页码:38 / 45
页数:8
相关论文
共 46 条
  • [1] BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
  • [2] TERBUTALINE-INDUCED DESENSITIZATION OF HUMAN-LYMPHOCYTE BETA-2-ADRENOCEPTORS - ACCELERATED RESTORATION OF BETA-ADRENOCEPTOR RESPONSIVENESS BY PREDNISONE AND KETOTIFEN
    BRODDE, OE
    BRINKMANN, M
    SCHEMUTH, R
    OHARA, N
    DAUL, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (03) : 1096 - 1101
  • [3] COREY SJ, 1989, J BIOL CHEM, V264, P14165
  • [4] BASAL AND ADENOSINE RECEPTOR-STIMULATED LEVELS OF CAMP ARE REDUCED IN LYMPHOCYTES FROM ALCOHOLIC PATIENTS
    DIAMOND, I
    WRUBEL, B
    ESTRIN, W
    GORDON, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (05) : 1413 - 1416
  • [5] Antimigraine drugs
    Diener, HC
    Kaube, H
    Limmroth, V
    [J]. JOURNAL OF NEUROLOGY, 1999, 246 (07) : 515 - 519
  • [6] FOZARD JR, 1985, VASCULAR NEUROEFFECT, P321
  • [7] Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception
    Galeotti, N
    Ghelardini, C
    Bartolini, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 308 (02) : 125 - 133
  • [8] Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel
    Galeotti, N
    Ghelardini, C
    Capaccioli, S
    Quattrone, A
    Nicolin, A
    Bartolini, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 330 (01) : 15 - 25
  • [9] A study of adaptive responses in cell signaling in migraine and cluster headache: correlations between headache type and changes in gene expression
    Gardiner, IM
    Ahmed, F
    Steiner, TJ
    McBain, A
    Kennard, C
    de Belleroche, J
    [J]. CEPHALALGIA, 1998, 18 (04) : 192 - 196
  • [10] THE TRIGEMINOVASCULAR SYSTEM AND MIGRAINE - STUDIES CHARACTERIZING CEREBROVASCULAR AND NEUROPEPTIDE CHANGES SEEN IN HUMANS AND CATS
    GOADSBY, PJ
    EDVINSSON, L
    [J]. ANNALS OF NEUROLOGY, 1993, 33 (01) : 48 - 56